High school youth have an elevated risk of substance use. Some substances (e.g., inhalants, MDMA) used by youth are overlooked or grouped in an "other" category. Compared to other racial/ethnic groups, American Indian (AI) youth may be at higher risk of using these substances. The purpose of this study is to examine the prevalence and patterns of use of "other" substances among youth living on...
Approximately 8.5 million Americans over the age of 12 endorsed past year psychedelic use in 2022, with 1.4 million individuals initiating use during this time. Although emerging evidence indicates there may be beneficial aspects of psychedelic use, there is a need to understand how individuals might mitigate potential risks within nonclinical contexts, such as through the use of protective...
Psilocybin use in nonclinical settings is heterogeneous. We identified three profiles that differed on frequency and quantity of use and their associated demographic characteristics. Next steps are to identify factors that affect one's likelihood of experiencing particular use outcomes and to explore use variability.